Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
Natalizumab in the pediatric MS population: results of the Italian registry.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Insights into TREM2 biology by network analysis of human brain gene expression data.
Review of Animal Models of Neuromyelitis Optica.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Defining the new end point for multiple sclerosis treatment.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.

Pages